Daratumumab (Darzalex▼): risk of reactivation of hepatitis B virus

2019-08-19T15:48:18+01:00

Establish hepatitis B virus status before initiating daratumumab and in patients with unknown hepatitis B virus serology who are already being treated with daratumumab.…